TENAX THERAPEUTICS, INC.·4

Jun 10, 9:19 PM ET

Hunter Robyn 4

4 · TENAX THERAPEUTICS, INC. · Filed Jun 10, 2022

Insider Transaction Report

Form 4
Period: 2022-06-09
Hunter Robyn
Director
Transactions
  • Award

    Stock Option (right to buy)

    2022-06-09+6,2506,250 total
    Exercise: $0.62From: 2023-06-09Exp: 2032-06-09Common Stock (6,250 underlying)

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT